michigan glp-1 intestinal paralysis class action Lawsuit GLP-1 Stomach Paralysis Risk: Clinical

GLP-1 Receptor Agonist Market Opportunities: Expanded cardiovascular indications and biosimilar development creating transformative GLP-1 receptor agonist market opportunities The cardiovascular indication expansion following SELECT trial approval for semaglutide in cardiovascular risk reduction in obese non-diabetic patients is qualitatively important because it changes who prescribes GLP-1 drugs

For general performance or anti-aging use, tesamorelin is sometimes prescribed off-label, but it is more expensive, more carefully monitored, and not typically the first line of conversation for a man without a specific clinical indication

Hirth N., Meinhardt M

Athletes may benefit from enhanced recovery, reduced oxidative stress, and improved endurance support

In contrast, ALOX12 is required for ferroptosis caused by TP53-mediated downregulation of SLC7A11 (Yang et al., 2022), none of the isoforms has yet been proven to play a decisive role in ferroptosis